According to an update from the U.S. Food & Drug Administration (FDA), Philips Respironics (Philips) in June 2021 recalled certain sleep and respiratory care devices including ventilators, bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines and continuous positive airway pressure (CPAP) machines because of potential health risks.
This item is available in full to subscribers.
To continue reading, you will need to either log into your subscriber account or purchase a new subscription.
If you are a digital subscriber with an active subscription, then you already have an online account. Please log in below to access this article.
If you are a current print subscriber, your subscription includes full access to our website. Please use your online account information to log in below to access this article. If you haven’t already, you can set up a free online account by by clicking here.
Click here if you need to reset your password.
Otherwise, click here to view your options for subscribing.
Please log in to continue |